INTRODUCTION
The inhibitory neurotransmitter GABA (Fig. 1 , structure 1), activates three major classes of receptors, termed GABA A , GABA B and GABA C receptors. These receptors have different characteristics: the GABA A and GABA C receptors are ionotropic, while the GABA B receptors are metabotropic.
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IONOTROPIC
GABA A AND GABA C RECEPTORS
The GABA A and GABA C receptors are Cl -; channels that mediate fast synaptic inhibition. Both the GABA A and GABA C receptors are members of a superfamily of transmitter-gated ion channels that includes the nicotinic acetylcholine, strychnine-sensitive glycine and 5HT3 receptors. These transmitter-gated ion channels are believed to be structurally very similar, composed of five subunits that arrange together to form an ion channel. Each subunit has four transmembrane domains. 2 When the channel forms, all five subunits arrange in such a way that their second transmembrane domains form the wall of the channel pore. Furthermore, there is a large intracellular loop between transmembrane domains three and four, which is believed to be the target for protein kinases and to be required for subcellular targetting and membrane clustering of the receptor. 2 It is in this region that the receptors can anchor to the cytoskeleton. Both the C-and N-terminal regions lie extracellular to the cell surface and part of the agonist/antagonist binding site lies within the Nterminal region. 2 GABA A and GABA C receptors are biochemically, pharmacologically and physiologically different. 3, 4 GABA is an order of magnitude less potent at GABA A than GABA C receptors. GABA A receptors are selectively blocked by the alkaloid bicuculline and are modulated by benzodiazepines, steroids and barbiturates. (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA; Fig. 1 , structure 4). 6, 7 Very little is known about chemical modulators for the GABA C receptors.
To date, there are 16 human GABA A receptor subunits (α1-6, β1-4, γ1-4, δ, ε) 1, 8 and two human GABA C receptor subunits (ρ1 and ρ2) [9] [10] [11] that have been cloned. There is approximately 30% sequence identity between the subunits and approximately 70% sequence identity between subunit subtypes. 12 GABA A receptors are hetero-oligomeric, made up of a mixture of α1-6, β1-4, γ1-4, δ and ε subunits. Consequently, an enormous array of combinations may exist for these receptor subtypes. However, for a fully functional GABA A receptor, it appears that an α, β and one other subunit type, such as γ, δ or [small element of], are required.
1 In contrast, GABA C receptors are homo-oligomeric, made up of either ρ1 or ρ2 subunits, although there is increasing evidence that these receptors may be hetero-oligomeric, made up of a combination of the ρ subunits. 13 The ρ subunits do not assemble with α and β subunits to form a receptor. 14, 15 Thus, the composition of GABA C receptors is different to GABA A receptors.
Single channel electrophysiological studies using outside-out patches from rat retinal bipolar cells showed that GABA C receptors conducted less current than GABA A receptors.
3,4 When activated, GABA C receptors had a longer channel opening time and desensitized less readily with maintained agonist application. 3, 4 Recently, different associated proteins have been cloned that link these receptors to the cytoskeleton. 16, 17 GABA A receptors are linked via the γ2-subunit to the cytoskeleton by GABA A receptor-associated proteins (GABARAP), 16 while GABA C receptors are linked via the ρ1-subunit to the cytoskeleton by microtubuleassociated protein 1B (MAP-1B).
1 7 The fact that two different proteins associate with the GABA A and GABA C receptors allows these receptors to exist and function separately.
METABOTROPIC GABA B RECEPTORS
GABA B receptors are seven transmembrane receptors that activate the second messenger systems phospholipase C and adenylate cyclase and activate K + and Ca 2+ ion channels via Gcoupled proteins. 18 These receptors are selectively activated by (R)-(-)-baclofen and the phosphinic acid analogue of GABA (3-aminopropyl)phosphinic acid (CGP27492). The phosphonic and sulphonic acid analogues of (R)-(-)-baclofen, phaclofen and saclofen, respectively, selectively antagonize these receptors. 18 GABA B receptors produce slow, prolonged inhibitory signals and function to modulate the release of neurotransmitters. To date, three subunits have been cloned and are termed GABA BR1a , GABA BR1b and GABA B R2. [19] [20] [21] These subunits resemble metabotropic glutamate receptors. 19 When the GABA BR1a or GABA BR1b subunit is combined with the GABA BR2 subunit, fully functional GABA B receptors are formed when these subunits are expressed in Xenopus oocytes or mammalian cell expression systems. [20] [21] [22] [23] Double immunoprecipitation studies have shown that these subunit combinations also exist in vivo as either dimers or multimers. [20] [21] [22] [23] Therefore, GABA B receptors are hetero-oligomeric receptors, made up of a GABA BR1a or GABA BR1b subunit and a GABA BR2 subunit.
CONFORMATIONALLY RESTRICTED ANALOGUES OF GABA
GABA is a highly flexible molecule; therefore, it can attain many low-energy conformations that bind to the different GABA receptors. E-4-Aminobut-2-enoic acid (trans-4-aminocrotonic acid (TACA); Fig. 1 , structure 5) and CACA are two conformationally restricted analogues of GABA: TACA is in an extended conformation, while CACA is in a folded conformation.
GABA C receptors were first proposed when a series of conformationally restricted analogues of GABA, including TACA and CACA, were tested for their effects in depressing the firing of spinal interneurons of the cat. 24 All three compounds depressed the firing of spinal interneurons. However, it was only the effects of GABA and TACA that were blocked by bicuculline. Bicuculline did not block the effects of CACA. As CACA had no effect on glycine receptors, it was proposed that CACA activated a GABA receptor that was insensitive to bicuculline, while TACA activated a GABA receptor that was sensitive to bicuculline. This novel GABA receptor was further distinguished from GABA B receptors by the fact that CACA also depressed the firing of Renshaw cells in the cat, while baclofen did not have any effect. 24 Therefore, CACA activated a GABA receptor that was insensitive to both bicuculline and baclofen. This receptor was termed the GABA C receptor. 25 The effects of GABA, TACA and CACA were further investigated using recombinant GABA A and GABA C receptor subunit mRNA expressed in Xenopus oocytes. 26 3 H-CGP27492 binding to rat cortical membranes was used to determine the activity at GABA B receptors. 27 These studies further showed that CACA, the restricted analogue of GABA in the folded conformation, selectively activated GABA C receptors, while TACA, the restricted analogue of GABA in the extended conformation, was not selective. However, we cannot make a direct quantitative comparison with the GABA B receptors because the effects on GABA B receptors were assessed using a radioligand binding assay system, while effects on GABA A and GABA C receptors were assessed using functional assay systems.
EFFECTS OF MUSCIMOL AND THIP ON GABA A AND GABA C RECEPTORS
The compounds muscimol (Fig. 1, structure 6 ) and its conformationally restricted analogue 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP; Fig. 1, structure 7 ), act at both GABA A and GABA C receptors. Muscimol can exist in two low-energy conformations: one conformation is extended, while the other is partially folded. In the case of THIP, there are also two low-energy conformations. However, both of these exist in the partially folded conformation. The only difference between the two conformations is the orientation of the nitrogen: in one conformation the nitrogen is below and, in the other, the nitrogen is above the plane made by THIP.
At GABA A receptors, muscimol is an agonist while THIP is a partial agonist. 26, 28 At GABA C receptors, muscimol is a partial agonist 26, 29 while THIP is an antagonist. 29 Therefore, THIP can be used to pharmacologically distinguish these receptors. Muscimol and THIP are six-and twofold more potent, respectively, at GABA C than GABA A receptors. 29 Because the pharmacology of muscimol is similar at both GABA A and GABA C receptors, it cannot be used to pharmacologically distinguish GABA A and GABA C receptors. Therefore, further work into developing selective GABA A receptor agonists is required. In the meantime, one needs to exert caution when using muscimol and THIP as pharmacological tools to characterize GABA A receptors.
CGP35024, CGP44530 and CGP70523 were tested on GABA A , GABA B and GABA C receptors. Compounds were tested on the GABA A receptor subtype, the α1β2γ2 expressed in Xenopus oocytes and assessed using two electrode voltage clamp methodology (M Chebib et al., unpubl. obs., 1998). On GABA C receptors, compounds were tested using the ρ1 mRNA expressed in Xenopus oocytes and assessed using two electrode voltage clamp methodology. 30 On GABA B receptors, compounds were tested using &#91;3H&#93;-CGP27492 binding at rat cortical membranes.
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CGP35024, CGP44530 and CGP70523 had little effect on GABA A receptors, activated GABA B receptors and blocked GABA C receptors. At GABA C receptors, CGP44530 and CGP70523 were both weaker than CGP35024. These compounds were selective for GABA C receptors when compared with GABA A receptors but were not selective when compared with GABA B receptors. However, we cannot make a direct quantitative comparison of CGP35024, CGP44530 and CGP75023 with GABA B receptors because the effects on GABA B receptors were assessed using a radioligand binding assay system. Now that functional GABA B receptors can be expressed in Xenopus oocytes and other cell expression systems, [20] [21] [22] [23] this comparison can be achieved.
One reason for the apparently reduced selectivity of CGP44530 and CGP70523 for the GABA C receptors may be that these compounds are more flexible when compared with TACA and CACA. 30 With CGP44530 and CGP70523, there is less restricted rotation in the methylphosphinic acid group than with the carboxylic acid groups of TACA and CACA. If restricted analogues of GABA in the folded conformation selectively bind to GABA C receptors, then CGP44530, for example, binds in a partially folded conformation. This leaves the bond between the phosphorous and C1 carbon free to rotate (Fig. 1, structure 11) . Therefore, it is difficult to determine the space where the methylphosphinic acid group resides when binding to the receptor. Isoguvacine (Fig. 1, structure 12) is a conformationally restricted analogue of TACA in a partially folded conformation. It is a weak partial agonist at GABA C receptors 29, 31 and an agonist at GABA A receptors. 29 Replacing the carboxylic acid group of isoguvacine with a methylphosphinic acid group results in the compound TPMPA. This compound is a weak antagonist at GABA A receptors and a weak agonist at GABA B receptors. 6, 7 However, it is a highly potent and selective GABA C receptor antagonist. 6, 7, 31 In conclusion, reducing the number of conformations that GABA can attain helps determine which conformation(s) bind to the different GABA receptors. Conformationally restricted analogues of GABA in the folded conformation, such as the carboxylic acid derivatives CACA and (1S,2R)-(+)-CAMP, selectively activate GABA C receptors, while conformationally restricted analogues of GABA in the partially folded conformation, such as the methylphosphinic acid derivative TPMPA, selectively block GABA C receptors.
